Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Buy
9,227
+8,259
+853% +$262K 0.03% 363
2025
Q4
$28.3K Buy
+968
New +$25.6K ﹤0.01% 692
2025
Q2
$11K Sell
490
-2,340
-83% -$48K ﹤0.01% 768
2025
Q1
$59.1K Buy
2,830
+145
+5% +$3.04K 0.01% 607
2024
Q4
$57K Sell
2,685
-400
-13% -$8.77K 0.01% 589
2024
Q3
$71.6K Buy
3,085
+205
+7% +$4.82K 0.01% 530
2024
Q2
$64.1K Sell
2,880
-205
-7% -$4.38K 0.01% 555
2024
Q1
$68K Buy
3,085
+205
+7% +$4.17K 0.01% 532
2023
Q4
$53.8K Buy
2,880
+2,315
+410% +$42.1K 0.01% 578
2023
Q3
$10.6K Buy
+565
New +$10.6K ﹤0.01% 700
2022
Q3
Sell
-310
Closed -$5.22K 960
2022
Q2
$5.22K Buy
+310
New +$5.63K ﹤0.01% 843

Other funds holding IX

Atlas Capital Advisors's IX Position: Q1 2026 in Review

Atlas Capital Advisors increased its ORIX (IX) stake by 853% in Q1 2026, buying an estimated $262K and bringing the position to 9,227 shares worth $277K. The position accounts for 0.03% of the portfolio, ranked #363.

Atlas Capital Advisors first reported a position in IX in Q2 2022 and has held it in 11 quarters since. 280 funds tracked by Wall St. Rank hold IX as of Q1 2026.

  • Atlas Capital Advisors held 9,227 shares of ORIX worth $277K as of Q1 2026.
  • Atlas Capital Advisors bought 8,259 ORIX shares in Q1 2026, an estimated $262K.
  • ORIX made up 0.03% of Atlas Capital Advisors's portfolio in Q1 2026, its #363 holding.
  • Atlas Capital Advisors first reported a position in ORIX in Q2 2022 and has held it in 11 quarters since.
  • 280 funds tracked by Wall St. Rank held ORIX as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.